+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Bare-Metal Stents - Global Strategic Business Report

  • PDF Icon

    Report

  • 378 Pages
  • November 2026
  • Region: Global
  • Market Glass, Inc.
  • ID: 6110923
The global market for Bare-Metal Stents was valued at US$3.9 Billion in 2025 and is projected to reach US$5.5 Billion by 2032, growing at a CAGR of 5.1% from 2025 to 2032. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Global Bare-Metal Stents Market - Key Trends & Drivers Summarized

How Are Clinical Preferences and Treatment Accessibility Sustaining the Relevance of Bare-Metal Stents?

Despite the rapid advancement and adoption of drug-eluting stents, bare-metal stents continue to maintain a significant presence in interventional cardiology due to their specific clinical advantages and broader accessibility. Bare-metal stents, made primarily from stainless steel or cobalt-chromium alloys, are favored in cases where patients are unable to adhere to prolonged dual antiplatelet therapy, which is commonly required for drug-eluting stents. These stents allow for a shorter duration of post-procedure medication, making them suitable for elderly patients, individuals with bleeding risks, or those requiring urgent surgery shortly after stent placement. Additionally, bare-metal stents are often used in low-resource settings where cost is a critical consideration, as they are significantly less expensive than their drug-eluting counterparts. In many developing countries, public health systems and smaller clinics rely on these devices due to budget constraints, reinforcing their ongoing relevance. Furthermore, bare-metal stents have a long track record of safety, rapid endothelialization, and mechanical durability, which are valuable attributes in specific patient populations. As a result, interventional cardiologists continue to incorporate them into treatment plans where their unique benefits align with patient needs, reinforcing their role in a diverse range of clinical scenarios.

Why Are Material Advancements and Design Improvements Enhancing Bare-Metal Stent Performance?

Technological progress in metallurgy and engineering has significantly improved the performance and clinical outcomes of bare-metal stents in recent years. Modern stents are now manufactured using high-strength alloys such as cobalt-chromium and platinum-chromium, which provide better radial strength and radiopacity while allowing for thinner struts. Thinner struts contribute to faster endothelial healing and lower risk of restenosis, without compromising mechanical integrity. Additionally, advances in laser cutting and surface finishing technologies have enhanced the precision of stent architecture, resulting in better flexibility, conformability, and ease of deployment within tortuous vessels. Surface modifications and coatings are also being developed to reduce thrombogenicity and enhance biocompatibility, even in the absence of pharmacological coatings. Computational modeling and imaging-guided design processes have enabled the optimization of cell geometry to ensure consistent expansion, reduced arterial wall stress, and minimal recoil. These innovations are helping bare-metal stents deliver improved clinical outcomes while maintaining the advantages of lower cost and simpler post-procedure management. While they may not match the long-term restenosis prevention of drug-eluting stents in all cases, these advancements are narrowing the performance gap and offering a more refined treatment option for specific patient cohorts.

How Do Health System Constraints and Global Market Dynamics Influence Bare-Metal Stent Utilization?

The utilization of bare-metal stents across global healthcare systems is shaped by a complex interplay of economic, demographic, and policy factors. In many emerging economies, healthcare infrastructure is under strain due to increasing patient loads, limited budgets, and variable access to advanced medical technologies. In such environments, bare-metal stents remain a vital and cost-effective tool in the treatment of coronary artery disease. They are widely used in government-sponsored health programs, non-profit hospitals, and rural health facilities where affordability and immediate availability often outweigh long-term therapeutic optimization. Insurance coverage policies and reimbursement structures also influence stent selection, particularly in countries where public health funding does not cover high-cost interventions like drug-eluting stents. Additionally, the increasing prevalence of cardiovascular diseases in aging populations and low-income communities contributes to sustained demand for low-cost stenting solutions. In emergency procedures where rapid intervention is needed and the patient’s medication history or risk profile is unknown, clinicians may prefer bare-metal stents due to their simpler antiplatelet therapy requirements. Furthermore, ongoing clinical research and registry data collection are providing new insights into patient-specific outcomes, helping physicians make evidence-based choices that include bare-metal options in certain cases. These global market dynamics ensure that bare-metal stents remain relevant, particularly where clinical pragmatism intersects with economic realities.

What Is Driving the Growth of the Global Bare-Metal Stents Market?

The growth in the global bare-metal stents market is driven by a variety of interrelated clinical, economic, and technological factors. One of the key drivers is the continued need for affordable cardiovascular interventions in low- and middle-income countries where access to premium medical devices is still limited. Bare-metal stents offer a practical and cost-effective solution for healthcare systems aiming to expand the reach of interventional cardiology. Another major growth factor is the aging global population, which is increasing the incidence of coronary artery disease and the need for less invasive, rapidly deployable treatments. Bare-metal stents are often used in high-risk patients or those requiring non-cardiac surgery shortly after angioplasty, situations where short-duration antiplatelet therapy is advantageous. The increasing awareness of cardiovascular health and the expansion of diagnostic capabilities in previously underserved regions are also contributing to a broader base of patients eligible for stenting procedures. Technological refinements in stent design, along with improvements in delivery systems and procedural efficiency, are enhancing their clinical appeal. Additionally, favorable regulatory policies in certain markets and a well-established manufacturing and distribution network continue to support steady supply and adoption. As healthcare providers strive to balance clinical efficacy with cost control, the demand for bare-metal stents is expected to persist, especially in diverse and rapidly growing markets around the world.

Report Scope

The report analyzes the Bare-Metal Stents market, presented in terms of market value (US$). The analysis covers the key segments and geographic regions outlined below:
  • Segments: Product (Self-Expandable Stent, Balloon Expandable Stent); Material (Stainless Steel Material, Cobalt-Chromium Alloy Material, Other Materials); End-User (Hospitals End-User, Specialized Clinics / Centers End-User, Ambulatory Surgery Centers End-User)
  • Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Self-Expandable Stent segment, which is expected to reach US$3.9 Billion by 2032 with a CAGR of a 5.8%. The Balloon Expandable Stent segment is also set to grow at 3.6% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, valued at $1.1 Billion in 2025, and China, forecasted to grow at an impressive 8.9% CAGR to reach $1.2 Billion by 2032. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Bare-Metal Stents Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Bare-Metal Stents Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Bare-Metal Stents Market expected to evolve by 2032?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2032?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2025 to 2032.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of players such as Abbott Laboratories, Admedes GmbH, Alvimedica, AMG International GmbH, AndraTec GmbH and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the companies featured in this Bare-Metal Stents market report include:

  • Abbott Laboratories
  • Admedes GmbH
  • Alvimedica
  • AMG International GmbH
  • AndraTec GmbH
  • B. Braun Melsungen AG
  • Balton Sp. z o.o.
  • Biosensors International Group
  • BIOTRONIK SE & Co. KG
  • Boston Scientific Corporation
  • Cook Medical LLC
  • Cordis (Cardinal Health)
  • ENDOCOR GmbH
  • Hexacath
  • Lepu Medical Technology Co., Ltd.
  • Medinol Ltd.
  • Medtronic plc
  • MicroPort Scientific Corporation
  • Sahajanand Medical Technologies Pvt. Ltd.
  • Terumo Corporation

What Sets This Report Apart From Others?

  • Grounded in Domain Expert Perspectives: Incorporates perspectives emerging from domain experts across industry, enterprise and academia, adding context beyond conventional published research.
  • Captures Early Market Signals: Tracks shifts emerging through expert conversations, company activity and market-relevant discussions before they are fully reflected in traditional secondary research.
  • Draws From a Broad, Validated Intelligence Base: Brings together insights from conference sessions, keynotes, panel discussions, blogs, corporate disclosures, annual reports, institutional publications and other validated sources.
  • Connects Signals With Strategic Market Direction: Synthesizes these perspectives to identify where the market is moving, what is driving that movement and which developments are likely to matter most for strategy.
  • Provides In-Depth Company Intelligence: Extends beyond market-level analysis to examine the companies participating in and shaping the competitive environment.
  • Market Share Is Examined Where It Matters: A single global market share figure rarely tells the full story. Competitive structures can vary significantly across geographies. Where analytically relevant, the report extends market share analysis into major regions with the level of detail tailored to the structure and dynamics of each market.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
  • World Market Trajectories
  • How Trump's Tariffs Impact the Market? The Big Question on Everyone's Mind
  • Bare-Metal Stents - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Evolving Clinical Guidelines Throw the Spotlight on the Continued Relevance of Bare-Metal Stents
  • Cost Sensitivity in Emerging Markets Spurs Demand for Economical Stent Solutions
  • Growing Cardiac Patient Pool Expands Addressable Market Opportunity for Bare-Metal Stents
  • Here`s the Story: Why Bare-Metal Stents Remain Preferred in High Bleeding Risk Patients
  • Technological Advancements in Stent Design Strengthen Business Case for Next-Gen BMS
  • Declining Use of Dual Antiplatelet Therapy in Select Cases Drives Adoption of Bare-Metal Stents
  • Rising Healthcare Access in Low- and Middle-Income Countries Generates Demand for Cost-Effective Interventional Devices
  • Aging Global Population Sustains Growth Momentum in Coronary Artery Disease Interventions
  • Increased Focus on Short-Term Outcomes Throws the Spotlight on Rapid Endothelialization Offered by BMS
  • Clinical Evidence Supporting BMS in Specific Use-Cases Strengthens Physician Confidence and Uptake
  • Shifting Physician Preferences in Niche Indications Create New Pathways for Bare-Metal Stent Utilization
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Bare-Metal Stents Market Analysis of Annual Sales in US$ Million for Years 2020 through 2032
  • Table 2: World Recent Past, Current & Future Analysis for Bare-Metal Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 3: World Historic Review for Bare-Metal Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 4: World 13-Year Perspective for Bare-Metal Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2020, 2026 & 2032
  • Table 5: World Recent Past, Current & Future Analysis for Self-Expandable Stent by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 6: World Historic Review for Self-Expandable Stent by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 7: World 13-Year Perspective for Self-Expandable Stent by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 8: World Recent Past, Current & Future Analysis for Balloon Expandable Stent by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 9: World Historic Review for Balloon Expandable Stent by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 10: World 13-Year Perspective for Balloon Expandable Stent by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 11: World Recent Past, Current & Future Analysis for Stainless Steel Material by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 12: World Historic Review for Stainless Steel Material by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 13: World 13-Year Perspective for Stainless Steel Material by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 14: World Recent Past, Current & Future Analysis for Cobalt-Chromium Alloy Material by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 15: World Historic Review for Cobalt-Chromium Alloy Material by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 16: World 13-Year Perspective for Cobalt-Chromium Alloy Material by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 17: World Recent Past, Current & Future Analysis for Other Materials by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 18: World Historic Review for Other Materials by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 19: World 13-Year Perspective for Other Materials by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 20: World Recent Past, Current & Future Analysis for Hospitals End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 21: World Historic Review for Hospitals End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 22: World 13-Year Perspective for Hospitals End-User by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 23: World Recent Past, Current & Future Analysis for Specialized Clinics / Centers End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 24: World Historic Review for Specialized Clinics / Centers End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 25: World 13-Year Perspective for Specialized Clinics / Centers End-User by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 26: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 27: World Historic Review for Ambulatory Surgery Centers End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 28: World 13-Year Perspective for Ambulatory Surgery Centers End-User by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
III. MARKET ANALYSIS
UNITED STATES
  • Bare-Metal Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2026 (E)
CANADA
JAPAN
  • Bare-Metal Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2026 (E)
CHINA
  • Bare-Metal Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2026 (E)
EUROPE
  • Bare-Metal Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2026 (E)
FRANCE
  • Bare-Metal Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2026 (E)
GERMANY
  • Bare-Metal Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2026 (E)
ITALY
UNITED KINGDOM
  • Bare-Metal Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2026 (E)
SPAINRUSSIAREST OF EUROPE
ASIA-PACIFIC
  • Bare-Metal Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2026 (E)
AUSTRALIA
  • Bare-Metal Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2026 (E)
INDIA
  • Bare-Metal Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2026 (E)
SOUTH KOREAREST OF ASIA-PACIFIC
LATIN AMERICA
  • Bare-Metal Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2026 (E)
ARGENTINABRAZILMEXICOREST OF LATIN AMERICA
MIDDLE EAST
  • Bare-Metal Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2026 (E)
IRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EAST
AFRICA
  • Bare-Metal Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2026 (E)
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott Laboratories
  • Admedes GmbH
  • Alvimedica
  • AMG International GmbH
  • AndraTec GmbH
  • B. Braun Melsungen AG
  • Balton Sp. z o.o.
  • Biosensors International Group
  • BIOTRONIK SE & Co. KG
  • Boston Scientific Corporation
  • Cook Medical LLC
  • Cordis (Cardinal Health)
  • ENDOCOR GmbH
  • Hexacath
  • Lepu Medical Technology Co., Ltd.
  • Medinol Ltd.
  • Medtronic plc
  • MicroPort Scientific Corporation
  • Sahajanand Medical Technologies Pvt. Ltd.
  • Terumo Corporation

Table Information